These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 20303648)

  • 1. Downregulation of RhoB GTPase confers resistance to cisplatin in human laryngeal carcinoma cells.
    Cimbora-Zovko T; Fritz G; Mikac N; Osmak M
    Cancer Lett; 2010 Sep; 295(2):182-90. PubMed ID: 20303648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered cell-cell adhesion in cisplatin-resistant human carcinoma cells: a link between beta-catenin/plakoglobin ratio and cisplatin resistance.
    Cimbora-Zovko T; Ambriović-Ristov A; Loncarek J; Osmak M
    Eur J Pharmacol; 2007 Mar; 558(1-3):27-36. PubMed ID: 17234182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of caspase-8 activation pathway is a possible mechanism for CDDP resistance in human laryngeal squamous cell carcinoma, HEp-2 cells.
    Toyozumi Y; Arima N; Izumaru S; Kato S; Morimatsu M; Nakashima T
    Int J Oncol; 2004 Sep; 25(3):721-8. PubMed ID: 15289875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of Bcl-xL down-regulation in response to cisplatin is associated with chemoresistance in ovarian carcinoma cells.
    Villedieu M; Louis MH; Dutoit S; Brotin E; Lincet H; Duigou F; Staedel C; Gauduchon P; Poulain L
    Gynecol Oncol; 2007 Apr; 105(1):31-44. PubMed ID: 17275076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transport of cisplatin and bis-acetato-ammine-dichlorocyclohexylamine Platinum(IV) (JM216) in human ovarian carcinoma cell lines: identification of a plasma membrane protein associated with cisplatin resistance.
    Sharp SY; Rogers PM; Kelland LR
    Clin Cancer Res; 1995 Sep; 1(9):981-9. PubMed ID: 9816070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of intracellular nm23-H1 prevents cisplatin-induced DNA damage in oesophageal cancer cells: possible association with Na(+), K(+)-ATPase.
    lizuka N; Miyamoto K; Tangoku A; Hayashi H; Hazama S; Yoshino S; Yoshimura K; Hirose K; Yoshida H; Oka M
    Br J Cancer; 2000 Nov; 83(9):1209-15. PubMed ID: 11027435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of cell death events induced by anti-neoplastic drugs cisplatin, paclitaxel and 5-fluorouracil on human hepatoma cell lines: Possible mechanisms of cell resistance.
    Brenes O; Arce F; Gätjens-Boniche O; Díaz C
    Biomed Pharmacother; 2007 Jul; 61(6):347-55. PubMed ID: 17399942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel mechanisms of platinum drug resistance identified in cells selected for resistance to JM118 the active metabolite of satraplatin.
    Samimi G; Kishimoto S; Manorek G; Breaux JK; Howell SB
    Cancer Chemother Pharmacol; 2007 Feb; 59(3):301-12. PubMed ID: 16770583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance to Fas-mediated apoptosis in malignant tumours is rescued by KN-93 and cisplatin via downregulation of c-FLIP expression and phosphorylation.
    Yang BF; Xiao C; Li H; Yang SJ
    Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1245-51. PubMed ID: 17973862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SKY1 is involved in cisplatin-induced cell kill in Saccharomyces cerevisiae, and inactivation of its human homologue, SRPK1, induces cisplatin resistance in a human ovarian carcinoma cell line.
    Schenk PW; Boersma AW; Brandsma JA; den Dulk H; Burger H; Stoter G; Brouwer J; Nooter K
    Cancer Res; 2001 Oct; 61(19):6982-6. PubMed ID: 11585720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of midkine induces cisplatin resistance in human oral squamous cell carcinoma.
    Ota T; Jono H; Ota K; Shinriki S; Ueda M; Sueyoshi T; Nakatani K; Hiraishi Y; Wada T; Fujita S; Obayashi K; Shinohara M; Ando Y
    Oncol Rep; 2012 May; 27(5):1674-80. PubMed ID: 22344722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. c-Myc-induced chemosensitization is mediated by suppression of cyclin D1 expression and nuclear factor-kappa B activity in pancreatic cancer cells.
    Biliran H; Banerjee S; Thakur A; Sarkar FH; Bollig A; Ahmed F; Wu J; Sun Y; Liao JD
    Clin Cancer Res; 2007 May; 13(9):2811-21. PubMed ID: 17473215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. alpha(v)beta(3) Integrin-mediated drug resistance in human laryngeal carcinoma cells is caused by glutathione-dependent elimination of drug-induced reactive oxidative species.
    Brozovic A; Majhen D; Roje V; Mikac N; Jakopec S; Fritz G; Osmak M; Ambriovic-Ristov A
    Mol Pharmacol; 2008 Jul; 74(1):298-306. PubMed ID: 18441044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of survivin expression enhances sensitivity of cultured uveal melanoma cells to cisplatin treatment.
    Li H; Niederkorn JY; Neelam S; Alizadeh H
    Exp Eye Res; 2006 Jul; 83(1):176-82. PubMed ID: 16584731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IGFBP-3 hypermethylation-derived deficiency mediates cisplatin resistance in non-small-cell lung cancer.
    Ibanez de Caceres I; Cortes-Sempere M; Moratilla C; Machado-Pinilla R; Rodriguez-Fanjul V; Manguán-García C; Cejas P; López-Ríos F; Paz-Ares L; de CastroCarpeño J; Nistal M; Belda-Iniesta C; Perona R
    Oncogene; 2010 Mar; 29(11):1681-90. PubMed ID: 20023704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.
    Perego P; Giarola M; Righetti SC; Supino R; Caserini C; Delia D; Pierotti MA; Miyashita T; Reed JC; Zunino F
    Cancer Res; 1996 Feb; 56(3):556-62. PubMed ID: 8564971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inositol 1,4,5-trisphosphate (IP3) receptor type1 (IP3R1) modulates the acquisition of cisplatin resistance in bladder cancer cell lines.
    Tsunoda T; Koga H; Yokomizo A; Tatsugami K; Eto M; Inokuchi J; Hirata A; Masuda K; Okumura K; Naito S
    Oncogene; 2005 Feb; 24(8):1396-402. PubMed ID: 15608674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Improved therapeutic effectiveness by combining recombinant human RhoB with low-dose cisplatin in human lung cancer in nude mice].
    Hu XH; Wu WF; Qing Y; Song LF; Huang W; Wu Y; Li Y; Wu XH
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Jul; 42(4):475-9. PubMed ID: 21866629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human renal UOK130 tumor cells: a drug resistant cell line with highly selective over-expression of glutathione S-transferase-pi isozyme.
    Wang W; Liu G; Zheng J
    Eur J Pharmacol; 2007 Jul; 568(1-3):61-7. PubMed ID: 17509556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperthermic modulation of resistance to cis-diamminedichloroplatinum (II) in human larynx carcinoma cells.
    Beketić-Oresković L; Jaksić M; Oresković S; Osmak M
    Int J Hyperthermia; 1997; 13(2):205-14. PubMed ID: 9147146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.